Johns Hopkins Medicine
Johns Hopkins Medicine
How is it that more and more powerful opioids are appearing among street drugs? Elizabeth Tracey reports.
How is it that more and more powerful opioids are appearing among street drugs? Elizabeth Tracey reports.
How is it that more and more powerful opioids are appearing among street drugs? Elizabeth Tracey reports.
Monday 23rd September 2024
Explore the challenges of combating increasingly potent street opioids with expert insights from Eric Strain at Johns Hopkins.
1 minute
Informative
Honest
Eye-opening
Compassionate
Non-judgmental
About this podcast
Author:
Johns Hopkins Medicine
Overview:
Categories:
Understanding Addiction & Recovery
Navigating Alcohol Dependency
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Family Recovery from Addiction
Links:
Visit site
Episodes:
40 (View all)
Do you want to link to this podcast?
Get the buttons here!The Ever-Evolving Battle Against Powerful Street Opioids
Episode Overview
- New synthetic opioids are increasingly potent and dangerous.
- Prescription drug monitoring has reduced prescription opioid abuse.
- Heroin and fentanyl have emerged as major challenges.
- New substances like nitazines and xylazine complicate treatment.
- Expert calls for a slowdown in the development of new synthetics.
"It's like whack-a-mole. You take care of one issue, and another one pops up."
Ever wondered why the streets are flooded with increasingly powerful opioids? In this gripping episode, Elizabeth Tracey reports on the daunting challenge of keeping up with the ever-evolving landscape of street drugs. From fentanyl to carfentanil, xylazine to nitazines, each new substance is more potent and dangerous than the last. Substance use disorder expert Eric Strain from Johns Hopkins shares his insights, comparing the situation to a game of 'whack-a-mole'.
Just when one issue is addressed, another pops up, making it a never-ending battle. Strain discusses how prescription drug monitoring and physician education helped reduce prescription opioid abuse, only for heroin and then fentanyl to take its place. Now, with the emergence of nitazines and xylazine, the challenges continue to mount. Strain admits it's unclear why these new synthetics keep appearing but expresses a strong desire for a slowdown.
This episode is a must-listen for anyone interested in understanding the complexities and ongoing battles in the fight against opioid abuse. Tune in to hear expert perspectives and gain a deeper understanding of this critical issue.